NUVB
Nuvation Bio Inc. · Healthcare
Insiders bought $118K of Nuvation Bio Inc. in the last 12 months
1 insider bought on 1 day.
NUVB over the last year
Largest buyers, last 12 months
NUVB after insider buys
3 months after each buy, from the first price a copier could get.
12 buys since 2021 with 3 months of prices.
Every filing
32 insider filings since 2021, newest first
Gary Hattersley · Chief Scientific Officer
Stacy Markel · Chief People Officer
Kerry Wentworth · Chief Regulatory Officer
Philippe Sauvage · Chief Financial Officer
Robert Mashal · Director
Kerry Wentworth · Chief Regulatory Officer
Dongfang Liu · Chief Medical Officer
Kerry Wentworth · Chief Regulatory Officer
Dongfang Liu · Chief Medical Officer
Dongfang Liu · Chief Medical Officer
Dongfang Liu · Chief Medical Officer
Gary Hattersley · Chief Scientific Officer
Colleen Sjogren · Chief Commercial Officer
Kerry Wentworth · Chief Regulatory Officer
David Hung · President, CEO and 10% owner
David Hung · President, CEO and 10% owner
Robert Mashal · Director
Junyuan Jerry Wang · CEO, Anheart Therapeutics LTD.
Xiangmin Cui · Director
Xiangmin Cui · Director
Kim D Blickenstaff · Director
Oleg Nodelman · Director
Oleg Nodelman · Director
Kathryn E Falberg · Director
Omega Fund V, L.P. · 10% owner
Omega Fund V, L.P. · 10% owner
Oleg Nodelman · Director
Omega Fund V, L.P. · 10% owner
Omega Fund V, L.P. · 10% owner
Omega Fund V, L.P. · 10% owner
Oleg Nodelman · Director
Robert B Bazemore · Director
About Nuvation Bio Inc.
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing product candidates for cancer treatment. The company's lead product candidate is IBTROZI (taletrectinib), a ROS1 inhibitor for the treatment of patients with ROS1+ non-small cell lung cancer. It is also developing Safusidenib, an inhibitor of mutant isocitrate dehydrogenase 1 in phase 3 clinical trials for the maintenance treatment of high-risk or high-grade IDH1-mutant astrocytoma with safusidenib against placebo. The company was founded in 2018 and is headquartered in New York, New York.
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.